Zhao YM - Search Results

1

Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients.

Yang TT, Song XL, Zhao YM, Ye BD, Luo Y, Xiao HW, Chen Y, Fu HR, Yu J, Liu LZ, Lai XY, Ye YS, Lan JP, Huang H, Shi JM. Yang TT, et al. Among authors: zhao ym. Ann Hematol. 2022 Dec;101(12):2731-2741. doi: 10.1007/s00277-022-04983-9. Epub 2022 Nov 1. Ann Hematol. 2022. PMID: 36318288

2

[Celecoxib-induced apoptosis in acute promyelocytic leukemia cell line MR2 and its mechanism].

Xu Y, Zhao YM, Huang H. Xu Y, et al. Among authors: zhao ym. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Jul;36(4):319-24. doi: 10.3785/j.issn.1008-9292.2007.04.002. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007. PMID: 17717820 Chinese.

3

Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells.

Zhao YM, Li JY, Lan JP, Lai XY, Luo Y, Sun J, Yu J, Zhu YY, Zeng FF, Zhou Q, Huang H. Zhao YM, et al. Biochem Biophys Res Commun. 2008 May 16;369(4):1114-9. doi: 10.1016/j.bbrc.2008.03.011. Epub 2008 Mar 11. Biochem Biophys Res Commun. 2008. PMID: 18339310

4

Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition.

Zhao YM, Zhou Q, Xu Y, Lai XY, Huang H. Zhao YM, et al. Acta Pharmacol Sin. 2008 Apr;29(4):481-8. doi: 10.1111/j.1745-7254.2008.00767.x. Acta Pharmacol Sin. 2008. PMID: 18358095

5

Simultaneous occurrence of variant Philadelphia translocations and ABL mutations in two patients with chronic myeloid leukemia.

Zhao Y, Wu G, Wu K, Liu L, Cao W, Yu X, Luo Y, Shi J, Tan Y, Huang H. Zhao Y, et al. Leuk Res. 2009 Jul;33(7):e85-7. doi: 10.1016/j.leukres.2009.01.011. Epub 2009 Feb 8. Leuk Res. 2009. PMID: 19203793 No abstract available.

6

Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population.

Zhao Y, Liu L, Wang Y, Wu G, Lai X, Cao W, Luo Y, Tan Y, Shi J, Xie W, Ye X, Cai Z, Lin M, Huang H. Zhao Y, et al. Int J Hematol. 2009 May;89(4):445-451. doi: 10.1007/s12185-009-0292-7. Epub 2009 Apr 7. Int J Hematol. 2009. PMID: 19350352

7

Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia.

Luo Y, Zhao Y, Tan Y, Shi J, Han X, Zheng Y, Li L, He J, Xie W, Ye X, Cai Z, Lin M, Huang H. Luo Y, et al. Leuk Res. 2011 Oct;35(10):1307-11. doi: 10.1016/j.leukres.2011.01.001. Epub 2011 Feb 26. Leuk Res. 2011. PMID: 21354617

8

Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloid leukemia.

Zhao Y, Tan Y, Wu G, Liu L, Wang Y, Luo Y, Shi J, Huang H. Zhao Y, et al. Int J Hematol. 2011 Aug;94(2):156-162. doi: 10.1007/s12185-011-0887-7. Epub 2011 Jul 5. Int J Hematol. 2011. PMID: 21728004 Clinical Trial.

9

[Effects of blocking inhibitory KIR receptors on cytotoxic activity of human NK cells in vitro].

Wu GQ, Zhao YM, Huang H, Lai XY. Wu GQ, et al. Among authors: zhao ym. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011 Sep;40(5):475-81. doi: 10.3785/j.issn.1008-9292.2011.05.003. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011. PMID: 21984148 Chinese.

10

[Synergistic cytotoxic effects of rapamycin and idarubicin on human acute T-cell lymphoblastic leukemia Jurkat cells].

Zhao YM, Wu KN, Wang YJ, Wu GQ, Cao WJ, Yu XH, Huang H. Zhao YM, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011 Sep;40(5):482-8. doi: 10.3785/j.issn.1008-9292.2011.05.004. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011. PMID: 21984149 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

690 results

Search Page

Filters